E. Y. Kaushanskay

E. Y. Kaushanskay

Auto-generated profile, based on publicly available information

E. Y. Kaushanskay

Rostov State Medical University (Research Institute of Obstetrics and Pediatrics)

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2020 in Medical Herald of the South of Russia
Verified
Journal Article
Open access
PDF file
ALA. A. Lebedenko
A. A. Lebedenko
SBS. B. Berezhanskay
S. B. Berezhanskay
ATA. S. Todorova
A. S. Todorova
NVN. N. Vostrykh
N. N. Vostrykh
EKE. Y. Kaushanskay
E. Y. Kaushanskay
ЕКЕ. Я. Каушанская
Е. Я. Каушанская
Glutaric aciduria type I (deficiency of glutaryl-COA dehydrogenase, glutaric acidemia type I) is a rare autosomal recessive disease caused by mutations in the gene encoding the enzyme glutaryl – COA - dehydrogenase (GCDH). Cerebral organic aciduria, caused by a deficiency of glutaryl-COA - dehydrogenase, is generally considered a neurological disorder.The phenotypic spectrum of untreated GA-1 varies from a more common and pronounced form (a disease with infancy) to a low-symptom and less common form. In people with the same genotype, the clinical manifestations and depth of CNS damage can vary widely depending on the age of manifestation of acute encephalopathic crises. It is assumed that with early detection and treatment of “asymptomatic” newborns (in the context of screening for this disease), most people who would have developed manifestations of GA-1 with childhood or late onset will remain asymptomatic.